You are reading: Healthy Participants | The Respiratory Virus Vaccine Study (Visits Only)

Healthy Participants

The Respiratory Virus Vaccine Study (Visits Only)

Start date

Coming soon

Renumeration

$4,800

8-9 appointments, 1-2 phone calls

Help Test a New Vaccine for Respiratory Viruses

This clinical study is evaluating a new vaccine for Respiratory Viruses. The primary goal is to assess the safety and tolerability of the treatment in healthy adult participants.

Apply Now

Example Schedule

8 appointment

Day 1, Day 8, Day 15, Day 29, Day 43, Day 57, Day 113, Day 197, Day 364

To Qualify, You Must

Age

Be 18 to 55 years old

Gender

Both males or females

Physical Condition

Have no significant medical health conditions or allergies

Requirements

Have a BMI between 18 and 32kg/m2

Renumeration

$4,800-$5,150 *Screening Reimbursement of $100–$250 applies, please see Terms

Help Test a New Vaccine for Respiratory Viruses.

Spots are limited. Find out if you qualify today!

Apply Now